CEBPB and early-onset autosomal dominant Alzheimer disease: CEBPB was up-regulated in patients with Alzheimer’s disease, which increased the expression of pro-inflammatory genes in microglia, and the ubiquitin ligase COP1 inhibited neuroinflammation by silencing CEBPB in microglia [57].